Over 30 countries have expressed an interest to introduce pneumococcal vaccination as part of their public health efforts.

30 countries have expressed an interest to introduce pneumococcal vaccination as part of their public health efforts.

Progress & Next Steps

A lot has changed since 2003, when GAVI’s PneumoADIP began work to accelerate access to pneumococcal vaccines for developing countries. In the interim years, collaborative efforts by WHO, UNICEF, the GAVI Alliance, academia, foundations, industry, and developing country governments have led us to the brink of the introduction of pneumococcal vaccines in GAVI countries in 2008 – at least ten years faster than historical precedents. Based on the progress being made now and the foundation it has set for the future, we project that 5.4 million child deaths will be averted by 2030.

This emerging success story is the consequence of small and large efforts alike. Some of the major changes we have seen include:

  • WHO’s recommendation for the inclusion of pneumococcal vaccination in routine immunization programs
  • GAVI Board endorsement of the first ever Investment Case for Pneumococcal Vaccines
  • Global donors pledging US$1.5 billion for an Advance Market Commitment for pneumococcal vaccines
  • The commitment of multinational and emerging vaccine manufacturers to develop and supply pneumococcal vaccines to low-income countries
  • Expression of interest from 31 countries to introduce pneumococcal vaccination as part of their public health efforts

To read the Progress Update 2003-2007, click here.

To read the Progress Update in French, click here.

To read the Progress Update in Spanish, click here.

To read the Progress Update in Arabic, click here.

To read the Progress Update in Russian, click here.

To receive a copy of the Progress Update 2003-2007, please complete request form below.

 
 
The Pneumococcal vaccines Accelerated Development and Introduction Plan is based
at Johns Hopkins Bloomberg School of Public Health and is funded by GAVI Alliance.